(Q38078237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

review article

1 reference

title

Biomarkers for predicting future metastasis of human gastrointestinal tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Ronnie Tung Ping Poon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Roberta Pang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

31 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

3631-3656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-013-1266-8

23 February 2020

exact match

0 references

cites work

Tumor metastasis: mechanistic insights and clinical challenges

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Growth Factors and their receptors in cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

21 January 2018

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The value of carcinoembryonic antigen measurement in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Transient CEA increase at start of oxaliplatin combination therapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The etiology of hepatocellular carcinoma and consequences for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Issues in screening and surveillance for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Metastasis suppressors alter the signal transduction of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Soluble E-cadherin is a valid prognostic marker in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of snail in pancreatic cancer promotes metastasis and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

TWIST1 is expressed in colorectal carcinomas and predicts patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Snail as a key regulator of PRL-3 gene in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Beta-catenin and the morphogenesis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Peritoneal seeding of hepatocellular carcinoma: clinicopathological characteristics of 17 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of beta-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Up-regulated expression of type II very low density lipoprotein receptor correlates with cancer metastasis and has a potential link to β-catenin in different cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The relationship between cyclooxygenase-2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Integrin adhesion receptors in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Integrins in cancer: biological implications and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

SPARC is associated with gastric cancer progression and poor survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Cell adhesion molecules: role and clinical significance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Thymosin beta 4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Targeting focal adhesion kinase signaling in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

FAK is involved in invasion and metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Evaluation of the clinical significance of focal adhesion kinase and SRC expression in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

ShRNA-targeted MAP4K4 inhibits hepatocellular carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Role of growth factor receptor bound protein 7 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

PI3K/PTEN signaling in tumorigenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

PI3K/PTEN signaling in angiogenesis and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

mTOR signaling pathway is a target for the treatment of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

HOXB7 as a prognostic factor and mediator of colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Prognostic significance of CD24 expression in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Aldehyde dehydrogenase 1 expression is associated with poor prognosis in patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

The tumor microenvironment and its contribution to tumor evolution toward metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Overexpression of YKL-40 is an independent prognostic marker in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1266-8

Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers

21 January 2018

1 reference

12 December 2020

Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer

1 reference

12 December 2020

The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma

1 reference

12 December 2020

Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.

1 reference

12 December 2020

Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma.

1 reference

12 December 2020

Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Transcriptional repressor snail and progression of human hepatocellular carcinoma

1 reference

12 December 2020

Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer

1 reference

12 December 2020

The clinical significance of vimentin-expressing gastric cancer cells in bone marrow

1 reference

12 December 2020

Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma

1 reference

12 December 2020

A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer

1 reference

12 December 2020

Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer

1 reference

12 December 2020

The differential expression of SPARC in esophageal squamous cell carcinoma.

1 reference

12 December 2020

Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases

1 reference

12 December 2020

Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer

1 reference

12 December 2020

The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.

1 reference

12 December 2020

High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study

1 reference

12 December 2020

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions

1 reference

12 December 2020

Detection and clinical significance of CD44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay

1 reference

12 December 2020

Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma.

1 reference

12 December 2020

Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence

1 reference

12 December 2020

Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers

1 reference

12 December 2020

Osteopontin induced by macrophages contribute to metachronous liver metastases in colorectal cancer

1 reference

12 December 2020

Association of Vimentin overexpression and hepatocellular carcinoma metastasis

1 reference

12 December 2020

Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study

1 reference

12 December 2020

Significance of the serum level of soluble E-cadherin in patients with HCC

1 reference

12 December 2020

Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients

1 reference

12 December 2020

PRL-3 expression in metastatic cancers

1 reference

12 December 2020

Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma

1 reference

12 December 2020

Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.

1 reference

12 December 2020

Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients

1 reference

12 December 2020

Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma

1 reference

12 December 2020

Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients

1 reference

12 December 2020

Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin

1 reference

12 December 2020

Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer

1 reference

12 December 2020

Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma

1 reference

12 December 2020

Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness

1 reference

12 December 2020

Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer

1 reference

12 December 2020

The structure, metabolism and function of the carcinoembryonic antigen gene family

1 reference

12 December 2020

Clinical significance of serum soluble E-cadherin in colorectal carcinoma

1 reference

12 December 2020

Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.

1 reference

12 December 2020

Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer

1 reference

12 December 2020

Prognostic significance of osteopontin expression in human gastric carcinoma

1 reference

12 December 2020

Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer

1 reference

12 December 2020

Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis

1 reference

12 December 2020

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma

1 reference

12 December 2020

L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis

1 reference

12 December 2020

Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma

1 reference

12 December 2020

beta-Catenin and ras oncogenes detect most human colorectal cancer

1 reference

12 December 2020

High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis

1 reference

12 December 2020

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of endoglin (CD105) is associated with recurrence in radically resected gastric cancer.

1 reference

12 December 2020

Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer.

1 reference

12 December 2020

Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma

1 reference

12 December 2020

Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.

1 reference

12 December 2020

The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count

1 reference

12 December 2020

Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients.

1 reference

12 December 2020

Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer

1 reference

12 December 2020

Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China

1 reference

12 December 2020

Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP

1 reference

12 December 2020

Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer

1 reference

12 December 2020

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma

1 reference

12 December 2020

Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research

1 reference

12 December 2020

Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas

1 reference

12 December 2020

The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer

1 reference

12 December 2020

Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues

1 reference

12 December 2020

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma

1 reference

12 December 2020

Vimentin expression is associated with decreased survival in gastric cancer

1 reference

12 December 2020

Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma

1 reference

12 December 2020

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas

1 reference

12 December 2020

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients

1 reference

12 December 2020

The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

1 reference

12 December 2020

PTP4A3 (PRL-3) expression correlate with lymphatic metastases in gastric cancer.

1 reference

12 December 2020

A combination of serum markers for the early detection of colorectal cancer

1 reference

12 December 2020

Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry

1 reference

12 December 2020

Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery

1 reference

12 December 2020

10.1007/S00018-013-1266-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370778%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference